NCT06333821 2024-03-27A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical CarcinomaBiotech Pharmaceutical Co., Ltd.Phase 3 Not yet recruiting460 enrolled